Heplisav

The American Society of Clinical Oncology's 2018 annual meeting is scheduled to be held in Chicago, Illinois June 1-5. In a Thursday note, JPMorgan evaluated the prospects for Dynavax Technologies Corporation (NASDAQ: DVAX) in the coming month, especially ahead of the ASCO presentations....

Dynavax Technologies Corporation (NASDAQ: DVAX), a clinical-stage immunotherapy company, confirmed on Thursday the U.S. Food and Drug Administration approved its two-dose vaccine  The company failed to gain approval for its therapy in February 2013 and in November 2016. But now that the...